Jump to main content
Jump to site search

Issue 4, 2015
Previous Article Next Article

Label-free detection of Alzheimer’s disease through the ADP3 peptoid recognizing the serum amyloid-beta42 peptide

Author affiliations

Abstract

The early diagnosis of Alzheimer’s disease (AD) is challenging due to the lack of reliable methods for detecting its biomarkers in the noninvasive biopsies. We used surface plasmon resonance imaging to identify AD based on the detection of amyloid-beta42 in the serum by the ADP3 peptoid.

Graphical abstract: Label-free detection of Alzheimer’s disease through the ADP3 peptoid recognizing the serum amyloid-beta42 peptide

Back to tab navigation

Supplementary files

Article information


Submitted
06 Sep 2014
Accepted
18 Nov 2014
First published
18 Nov 2014

Chem. Commun., 2015,51, 718-721
Article type
Communication
Author version available

Label-free detection of Alzheimer’s disease through the ADP3 peptoid recognizing the serum amyloid-beta42 peptide

Z. Zhao, L. Zhu, X. Bu, H. Ma, S. Yang, Y. Yang and Z. Hu, Chem. Commun., 2015, 51, 718
DOI: 10.1039/C4CC07037B

Social activity

Search articles by author

Spotlight

Advertisements